MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

Historical Holders from Q2 2016 to Q3 2025

Symbol
MDGL on Nasdaq
CUSIP
558868105
Type / Class
Equity / Common Stock
Shares outstanding
22.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
23.4M
Holdings value
$10.7B
% of all portfolios
0.016%
Grand Portfolio weight change
0%
Number of holders
345
Number of buys
186
Number of sells
-145
Average Value change %
0%
Average buys %
+0.004%
Average sells %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 8.3% -16% $845M -$160M 1.84M -15.9% JANUS HENDERSON GROUP PLC Sep 30, 2025

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23.4M $10.7B -$22M $458.66 345
2025 Q2 23.6M $7.13B -$59M $302.64 303
2025 Q1 23.6M $7.82B +$242M $331.23 317
2024 Q4 23M $7.08B +$149M $308.57 281
2024 Q3 22.6M $4.75B -$130M $212.22 258
2024 Q2 22.9M $6.41B +$530M $280.16 263
2024 Q1 21M $5.61B +$314M $267.04 274
2023 Q4 338K $78.4M +$16.3M $231.60 2
2023 Q3 17M $2.48B +$300M $146.04 204
2023 Q2 14.7M $3.39B +$195M $231.00 205
2023 Q1 13.9M $3.36B +$106M $242.26 220
2022 Q4 13.3M $3.86B +$563M $290.25 184
2022 Q3 11.7M $763M -$25.1M $64.99 132
2022 Q2 12M $858M -$17.3M $71.58 130
2022 Q1 12M $1.18B +$28.3M $98.12 131
2021 Q4 11.9M $1.01B +$43.1M $84.74 138
2021 Q3 11M $874M -$34.1M $79.79 129
2021 Q2 11.2M $1.09B -$100M $97.41 147
2021 Q1 12.2M $1.43B -$10.2M $116.97 135
2020 Q4 12.3M $1.36B +$68.9M $111.17 132
2020 Q3 11.6M $1.38B +$47.8M $118.73 124
2020 Q2 11.3M $1.27B +$4.84M $113.25 124
2020 Q1 11M $737M +$26.6M $66.76 102
2019 Q4 10.5M $954M +$66.2M $91.11 118
2019 Q3 9.62M $829M -$306K $86.22 105
2019 Q2 9.6M $1.01B +$18.5M $104.81 112
2019 Q1 9.45M $1.18B +$61.3M $125.26 129
2018 Q4 8.98M $1.01B -$4.92M $112.72 129
2018 Q3 8.57M $1.83B +$67M $214.13 150
2018 Q2 8.03M $2.24B +$568M $279.69 144
2018 Q1 6.33M $739M +$153M $116.79 97
2017 Q4 5.13M $469M +$233M $91.79 87
2017 Q3 2.67M $120M +$29.4M $44.98 48
2017 Q2 2.03M $33M +$8.65M $16.26 35
2017 Q1 1.53M $23.5M +$3M $15.40 23
2016 Q4 1.35M $20M +$6.3M $14.90 23
2016 Q3 1.01M $12.8M +$12.7M $12.67 23
2016 Q2 79.6K $21K +$21K $0.26 1